Wellplayed: A Pilot Randomized Controlled Feasibility Trial of a Music Therapy-Informed Digital Psychosocial Intervention for Individuals Affected by Cancer
Summary
This study is testing a music-based app that may help support wellbeing in people affected by cancer. The app guides users through simple music activities designed to help with reflection and emotional support.
If you take part, you will use the app at home for about 3 weeks and complete short online questionnaires at three different times. Some participants will start using the app right away, while others will start after a short waiting period.
We want to learn if the app is easy to use, helpful, and something people would want to use in the future.
Eligibility
Eligible ages: 18 to 99
Inclusion criteria:
You may be eligible to participate if you:
Are 18 years of age or older
Have a current or past diagnosis of cancer
Are able to read and understand English
Have access to a smartphone, tablet, or computer with internet
Feel comfortable using a digital app and completing short online questionnaires
Exclusion criteria:
People who do not meet the inclusion criteria.
Participate
Fill out the following form if you want to participate in this research
UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is
committed to ensuring the privacy of all students, staff, and community members. Your personal information is being
collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used
and disclosed for the purposes outlined in UCalgary’s
Notice of
Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s
Privacy
Management Program.
Your personal information may be input into automated systems to generate content or make decisions,
recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection,
use, or disclosure of your personal information, please contact
accessandprivacy@ucalgary.ca.
Additional information
Contact information
Dr. Linda E. Carlson & Renee Pi (Research Coordinator)
Principal investigator:
Linda Ellen Carlson
Clinical trial:
Yes
REB-ID:
HREBA.CC-26-0035